Ads
related to: lung cancer- Confirm Mutational Status
Eligible mNSCLC Patient Should Be
Tested For Actionable Mutations.
- Metastatic NSCLC Testing
HCPs: Understand Your Patients'
Full Molecular Profiles. Learn More
- The Importance Of Testing
One Missed Patient Is One Too Many.
Visit Site For mNSCLC Testing Info.
- Don't Force Fit IO
1L IO May Not Be The Right Therapy
Option For Certain mNSCLC Patients.
- HCPs: It’s Up To You
Test mNSCLC Patients For Mutations
To Help Determine Treatment Options
- 1L Treatment Info
HCPs: It Is Up To You To Determine
If 1L Immunotherapy Is Appropriate.
- Confirm Mutational Status
Search results
Stress from living in violent neighborhoods tied to aggressive lung cancer in Black men
Medical Xpress· 3 days agoExposure to increased neighborhood violence has the power to change the glucocorticoid receptor (GR)...
Bristol’s $250,000 Pill Slows Lung Cancer Growth by Seven Weeks
Bloomberg· 5 days agoHave a confidential tip for our reporters? A Bristol Myers Squibb Co. lung cancer treatment delayed...
Unprecedented PFS Results in ALK-Positive Lung Cancer Trial
MedPage Today· 7 days agoFive-year results from a phase III trial had experts gushing over lorlatinib's (Lorbrena)...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
FOX Business· 6 days agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival
Reuters· 6 days ago, opens new tab Trodelvy failed to improve survival for patients with advanced bladder cancer and...
Virtual and In-Person Palliative Care Equally Beneficial in Advanced Lung Cancer
MedPage Today· 5 days agoEarly palliative care delivered via video was as effective as in-person visits on quality-of-life...
Strong Trial Results For Pfizer Lung Cancer Drug
International Business Times· 6 days agoA Pfizer medicine has been shown to greatly reduce cancer progression and improve survival outcomes for people in the advanced stages of a form of lung ...
Gilead’s Trodelvy extends lung cancer survival by just 1.3 months in trial
WHTC 1450 Holland· 6 days agoBy Deena Beasley (Reuters) - Gilead Sciences' Trodelvy improved survival by 1.3 months more than...
Strong trial results for Pfizer lung cancer drug
Medical Xpress· 6 days agoA Pfizer medicine has been shown to greatly reduce cancer progression and improve survival outcomes for people in the advanced stages of a form of lung ...
Strong trial results for Pfizer lung cancer drug
Fox Bangor· 6 days agoA Pfizer medicine has been shown to greatly reduce cancer progression and improve survival outcomes for people in the advanced stages of a form of lung ...